Retour

Intellia Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress

Stocks Earnings Releases and Operating Results

CAMBRIDGE, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today reported operational highlights and financial results for the first quarter ended March 31, 2024.

GlobeNewswire Inc. • 09/05/2024 à 13:30:00
Intellia Therapeutics, Inc
Address: 40 ERIE STREET
Postal Code: 02139
City: CAMBRIDGE
State: MA
Phone Number: 857-285-6200
Website: https://www.intelliatx.com
Status: Active
Company Info

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

List Date2016-05-06
MarketStocks
LocalUS
Primary ExchangeXNAS
TypeCS
Currency NameUSD
CIK0001652130
Composite figiBBG007KC7PB0
Share Class figiBBG007KC7PC9
Market Cap2,529,585,539 USD
SIC Code2835
SIC DescriptionIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Total Employees598
Share Class Shares Outstanding96480000
Weighted Shares Outstanding96475421
Round Lot100
Updated date2024-05-19
Stats
Last 5 days
17-05
16-05
15-05
14-05
13-05
Last
26.12
26.041
26.545
25.54
25.375
Variance
0.3%
-1.9%
3%
0.61%
5.88%
Open
26.042
26.545
25.772
25.385
23.965
Highest
26.54
26.625
27.142
26.879
26.738
Lowest
26.51
26.625
27.043
26.719
26.684
History
PeriodVarhighestlowest
1 week
8.99%
26.738
26.51
1 month
21.07%
22.945
20.946
3 month
-6.38%
28.071
20.946
6 month
-8.58%
31.59
20.946
1 year
-37.82%
44.48
20.946
3 year
-59.91%
67.78
20.946
5 year
69.28%
15.52
9.18
10 year
18.73%
24
9.18
Stock Financials
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-04 2023-08-03 2023-11-09 UNPUB
Assets 1,417,889,000 1,323,240,000 1,243,349,000 UNPUB
Current Assets 963,671,000 939,615,000 893,493,000 UNPUB
Current Liabilities 103,383,000 99,851,000 91,953,000 UNPUB
Equity 1,190,843,000 1,104,888,000 1,037,414,000 UNPUB
Equity Attributable To Noncontrolling Interest 0 0 0 UNPUB
Equity Attributable To Parent 1,190,843,000 1,104,888,000 1,037,414,000 UNPUB
Liabilities 227,046,000 218,352,000 205,935,000 UNPUB
Liabilities And Equity 1,417,889,000 1,323,240,000 1,243,349,000 UNPUB
Noncurrent Assets 454,218,000 383,625,000 349,856,000 UNPUB
Noncurrent Liabilities 123,663,000 118,501,000 113,982,000 UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-04 2023-08-03 2023-11-09 UNPUB
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -229,355,000 -122,345,000 -2,779,000 UNPUB
Net Cash Flow, Continuing -229,355,000 -122,345,000 -2,779,000 UNPUB
Net Cash Flow From Financing Activities 2,221,000 2,516,000 19,102,000 UNPUB
Net Cash Flow From Financing Activities, Continuing 2,221,000 2,516,000 19,102,000 UNPUB
Net Cash Flow From Investing Activities -122,248,000 -34,538,000 79,500,000 UNPUB
Net Cash Flow From Investing Activities, Continuing -122,248,000 -34,538,000 79,500,000 UNPUB
Net Cash Flow From Operating Activities -109,328,000 -90,323,000 -101,381,000 UNPUB
Net Cash Flow From Operating Activities, Continuing -109,328,000 -90,323,000 -101,381,000 UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-04 2023-08-03 2023-11-09 UNPUB
Comprehensive Income/Loss -98,343,000 -124,871,000 -121,928,000 UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Comprehensive Income/Loss Attributable To Parent -98,343,000 -124,871,000 -121,928,000 UNPUB
Other Comprehensive Income/Loss 4,783,000 -124,871,000 -121,928,000 UNPUB
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-04 2023-08-03 2023-11-09 UNPUB
Basic Earnings Per Share -1 -1 -1 UNPUB
Benefits Costs and Expenses 115,732,000 145,928,000 143,099,000 UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 124,564,000 145,928,000 143,099,000 UNPUB
Diluted Earnings Per Share -1 -1 -1 UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -103,126,000 -123,681,000 -122,224,000 UNPUB
Income/Loss From Continuing Operations Before Tax -103,126,000 -132,334,000 -131,107,000 UNPUB
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -103,126,000 -123,681,000 -122,224,000 UNPUB
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Net Income/Loss Attributable To Parent -103,126,000 -123,681,000 -122,224,000 UNPUB
Net Income/Loss Available To Common Stockholders, Basic -103,126,000 -123,681,000 -122,224,000 UNPUB
Operating Expenses 124,564,000 145,928,000 143,099,000 UNPUB
Operating Income/Loss -111,958,000 -132,334,000 -131,107,000 UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 UNPUB
Preferred Stock Dividends And Other Adjustments 0 0 0 UNPUB
Revenues 12,606,000 13,594,000 11,992,000 UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2022-08-04 2022-11-03 2023-02-23
Assets UNPUB 1,110,424,000 1,084,458,000 1,520,114,000
Current Assets UNPUB 895,433,000 858,947,000 1,216,797,000
Current Liabilities UNPUB 123,760,000 131,132,000 126,554,000
Equity UNPUB 880,547,000 824,951,000 1,235,584,000
Equity Attributable To Noncontrolling Interest UNPUB 0 0 0
Equity Attributable To Parent UNPUB 880,547,000 824,951,000 1,235,584,000
Liabilities UNPUB -880,547,000 259,507,000 284,530,000
Liabilities And Equity UNPUB 1,110,424,000 1,084,458,000 1,520,114,000
Noncurrent Assets UNPUB 214,991,000 225,511,000 303,317,000
Noncurrent Liabilities UNPUB 0 128,375,000 157,976,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2022-08-04 2022-11-03 2023-02-23
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow UNPUB UNPUB -6,906,000 409,977,000
Net Cash Flow, Continuing UNPUB UNPUB -6,906,000 409,977,000
Net Cash Flow From Financing Activities UNPUB UNPUB 23,977,000 582,955,000
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB 23,977,000 582,955,000
Net Cash Flow From Investing Activities UNPUB UNPUB 47,643,000 160,309,000
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB 47,643,000 160,309,000
Net Cash Flow From Operating Activities UNPUB UNPUB -78,526,000 -333,287,000
Net Cash Flow From Operating Activities, Continuing UNPUB UNPUB -78,526,000 -333,287,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2022-08-04 2022-11-03 2023-02-23
Comprehensive Income/Loss UNPUB -100,678,000 -113,043,000 -479,015,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest UNPUB 0 0 0
Comprehensive Income/Loss Attributable To Parent UNPUB -102,170,000 -113,043,000 -479,015,000
Other Comprehensive Income/Loss UNPUB 0 -113,043,000 -4,829,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB -3,192,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2022-08-04 2022-11-03 2023-02-23
Basic Earnings Per Share UNPUB -1 -1 -6
Benefits Costs and Expenses UNPUB 112,331,000 118,796,000 526,307,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB 112,331,000 118,796,000 510,285,000
Diluted Earnings Per Share UNPUB -1 -1 -6
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax UNPUB -100,678,000 -113,229,000 -474,186,000
Income/Loss From Continuing Operations Before Tax UNPUB -100,678,000 -105,530,000 -474,186,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss UNPUB -100,678,000 -113,229,000 -474,186,000
Net Income/Loss Attributable To Noncontrolling Interest UNPUB 0 0 0
Net Income/Loss Attributable To Parent UNPUB -100,678,000 -113,229,000 -474,186,000
Net Income/Loss Available To Common Stockholders, Basic UNPUB -100,678,000 -113,229,000 -474,186,000
Operating Expenses UNPUB 112,331,000 118,796,000 510,285,000
Operating Income/Loss UNPUB -98,301,000 -105,530,000 -458,164,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic UNPUB 0 0 0
Preferred Stock Dividends And Other Adjustments UNPUB 0 0 0
Revenues UNPUB 14,030,000 13,266,000 52,121,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-06 2021-08-05 2021-11-04 2022-02-24
Assets 716,891,000 672,243,000 1,334,961,000 1,294,464,000
Current Assets 601,084,000 549,404,000 814,774,000 769,303,000
Current Liabilities 60,702,000 73,963,000 97,567,000 125,833,000
Equity 545,873,000 494,813,000 1,107,098,000 1,040,244,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 545,873,000 494,813,000 1,107,098,000 1,040,244,000
Liabilities -545,873,000 -494,813,000 227,863,000 254,220,000
Liabilities And Equity 716,891,000 672,243,000 1,334,961,000 1,294,464,000
Noncurrent Assets 115,807,000 122,839,000 520,187,000 525,161,000
Noncurrent Liabilities 0 0 130,296,000 128,387,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-06 2021-08-05 2021-11-04 2022-02-24
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -19,323,000 -12,588,000 204,277,000 -39,120,000
Net Cash Flow, Continuing -19,323,000 -12,588,000 204,277,000 -39,120,000
Net Cash Flow From Financing Activities 58,595,000 7,133,000 668,680,000 736,688,000
Net Cash Flow From Financing Activities, Continuing 58,595,000 7,133,000 668,680,000 736,688,000
Net Cash Flow From Investing Activities -25,542,000 33,260,000 -399,381,000 -550,778,000
Net Cash Flow From Investing Activities, Continuing -25,542,000 33,260,000 -399,381,000 -550,778,000
Net Cash Flow From Operating Activities -52,376,000 -52,981,000 -65,022,000 -225,030,000
Net Cash Flow From Operating Activities, Continuing -52,376,000 -52,981,000 -65,022,000 -225,030,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-06 2021-08-05 2021-11-04 2022-02-24
Comprehensive Income/Loss -46,205,000 -68,806,000 -71,805,000 -270,525,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -46,218,000 -68,807,000 -71,805,000 -270,525,000
Other Comprehensive Income/Loss 0 0 -71,805,000 -2,633,000
Other Comprehensive Income/Loss Attributable To Parent -13,000 -1,000 -161,000 -507,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-06 2021-08-05 2021-11-04 2022-02-24
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 52,650,000 75,567,000 79,197,000 300,945,000
Cost Of Revenue UNPUB UNPUB UNPUB 0
Costs And Expenses 52,870,000 75,567,000 79,197,000 300,903,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -46,205,000 -68,806,000 -71,644,000 -267,892,000
Income/Loss From Continuing Operations Before Tax -46,205,000 -68,806,000 -71,993,000 -267,892,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -46,205,000 -68,806,000 -71,644,000 -267,892,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -46,205,000 -68,806,000 -71,644,000 -267,892,000
Net Income/Loss Available To Common Stockholders, Basic -46,205,000 -68,806,000 -71,644,000 -267,892,000
Operating Expenses 52,870,000 75,567,000 79,197,000 300,903,000
Operating Income/Loss -46,425,000 -69,017,000 -71,993,000 -267,850,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 6,445,000 6,550,000 7,204,000 33,053,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-07 2020-08-06 2020-11-05 2021-02-26
Assets 314,752,000 490,830,000 458,555,000 676,322,000
Current Assets 269,760,000 446,367,000 416,250,000 616,517,000
Current Liabilities 35,304,000 59,142,000 55,865,000 64,254,000
Equity 247,759,000 351,587,000 329,620,000 527,072,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 247,759,000 351,587,000 329,620,000 527,072,000
Liabilities -247,759,000 -351,587,000 128,935,000 149,250,000
Liabilities And Equity 314,752,000 490,830,000 458,555,000 676,322,000
Noncurrent Assets 44,992,000 44,463,000 42,305,000 59,805,000
Noncurrent Liabilities 0 0 73,070,000 84,996,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-07 2020-08-06 2020-11-05 2021-02-26
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 23,767,000 282,605,000 -181,941,000 107,380,000
Net Cash Flow, Continuing 23,767,000 282,605,000 -181,941,000 107,380,000
Net Cash Flow From Financing Activities 4,864,000 132,225,000 597,000 371,779,000
Net Cash Flow From Financing Activities, Continuing 4,864,000 132,225,000 597,000 371,779,000
Net Cash Flow From Investing Activities 57,448,000 92,963,000 -153,980,000 -214,487,000
Net Cash Flow From Investing Activities, Continuing 57,448,000 92,963,000 -153,980,000 -214,487,000
Net Cash Flow From Operating Activities -38,545,000 57,417,000 -28,558,000 -49,912,000
Net Cash Flow From Operating Activities, Continuing -38,545,000 57,417,000 -28,558,000 -49,912,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-07 2020-08-06 2020-11-05 2021-02-26
Comprehensive Income/Loss -31,806,000 -32,393,000 -27,840,000 -134,491,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -31,694,000 -32,611,000 -27,964,000 -134,491,000
Other Comprehensive Income/Loss 0 0 0 -260,000
Other Comprehensive Income/Loss Attributable To Parent 112,000 -218,000 -124,000 -260,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-07 2020-08-06 2020-11-05 2021-02-26
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 45,964,000 49,297,000 50,322,000 192,225,000
Cost Of Revenue UNPUB UNPUB UNPUB 0
Costs And Expenses 45,964,000 49,297,000 50,322,000 194,577,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -31,806,000 -32,393,000 -27,840,000 -134,231,000
Income/Loss From Continuing Operations Before Tax -33,048,000 -33,034,000 -28,102,000 -134,231,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -31,806,000 -32,393,000 -27,840,000 -134,231,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -31,806,000 -32,393,000 -27,840,000 -134,231,000
Net Income/Loss Available To Common Stockholders, Basic -31,806,000 -32,393,000 -27,840,000 -134,231,000
Operating Expenses 45,964,000 49,297,000 50,322,000 194,577,000
Operating Income/Loss -33,048,000 -33,034,000 -28,102,000 -136,583,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 12,916,000 16,263,000 22,220,000 57,994,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-02 2019-08-01 2019-10-31 2020-02-27
Assets 344,363,000 352,441,000 346,635,000 334,280,000
Current Assets 303,693,000 307,137,000 295,935,000 289,481,000
Current Liabilities 39,234,000 38,463,000 37,519,000 35,633,000
Equity 264,338,000 276,866,000 275,652,000 269,881,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 264,338,000 276,866,000 275,652,000 269,881,000
Liabilities -264,338,000 -276,866,000 70,983,000 64,399,000
Liabilities And Equity 344,363,000 352,441,000 346,635,000 334,280,000
Noncurrent Assets 40,670,000 45,304,000 50,700,000 44,799,000
Noncurrent Liabilities 0 0 33,464,000 28,766,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-02 2019-08-01 2019-10-31 2020-02-27
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -11,759,000 2,043,000 -10,700,000 -1,630,000
Net Cash Flow, Continuing -11,759,000 2,043,000 -10,700,000 -1,630,000
Net Cash Flow From Financing Activities 3,999,000 6,471,000 46,400,000 76,434,000
Net Cash Flow From Financing Activities, Continuing 3,999,000 6,471,000 46,400,000 76,434,000
Net Cash Flow From Investing Activities 5,695,000 23,249,000 -31,652,000 25,176,000
Net Cash Flow From Investing Activities, Continuing 5,695,000 23,249,000 -31,652,000 25,176,000
Net Cash Flow From Operating Activities -21,453,000 -27,677,000 -25,448,000 -103,240,000
Net Cash Flow From Operating Activities, Continuing -21,453,000 -27,677,000 -25,448,000 -103,240,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-02 2019-08-01 2019-10-31 2020-02-27
Comprehensive Income/Loss -21,940,000 -25,683,000 -23,634,000 -99,244,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -21,853,000 -25,487,000 -23,553,000 -99,244,000
Other Comprehensive Income/Loss 0 0 0 289,000
Other Comprehensive Income/Loss Attributable To Parent 87,000 196,000 81,000 289,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-02 2019-08-01 2019-10-31 2020-02-27
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 34,242,000 38,578,000 35,944,000 142,636,000
Cost Of Revenue 0 0 0 0
Costs And Expenses 34,242,000 38,578,000 35,944,000 149,471,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -21,940,000 -25,683,000 -23,634,000 -99,533,000
Income/Loss From Continuing Operations Before Tax -23,809,000 -27,460,000 -25,328,000 -99,533,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -21,940,000 -25,683,000 -23,634,000 -99,533,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -21,940,000 -25,683,000 -23,634,000 -99,533,000
Net Income/Loss Available To Common Stockholders, Basic -21,940,000 -25,683,000 -23,634,000 -99,533,000
Operating Expenses 34,242,000 38,578,000 35,944,000 149,471,000
Operating Income/Loss -23,809,000 -27,460,000 -25,328,000 -106,368,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 10,433,000 11,118,000 10,616,000 43,103,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-01 2018-08-01 2018-10-31 2019-02-27
Assets 359,545,000 339,778,000 321,233,000 347,315,000
Current Assets 337,720,000 317,629,000 298,829,000 324,977,000
Current Liabilities 25,583,000 25,169,000 25,915,000 40,572,000
Equity 295,499,000 279,336,000 263,270,000 277,920,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 295,499,000 279,336,000 263,270,000 277,920,000
Liabilities 64,046,000 60,442,000 57,963,000 69,395,000
Liabilities And Equity 359,545,000 339,778,000 321,233,000 347,315,000
Noncurrent Assets 21,825,000 22,149,000 22,404,000 22,338,000
Noncurrent Liabilities 38,463,000 35,273,000 32,048,000 28,823,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-01 2018-08-01 2018-10-31 2019-02-27
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -12,900,000 -22,240,000 -12,290,000 -281,822,000
Net Cash Flow, Continuing -12,900,000 -22,240,000 -12,290,000 -281,822,000
Net Cash Flow From Financing Activities 6,720,000 1,155,000 2,180,000 40,217,000
Net Cash Flow From Financing Activities, Continuing 6,720,000 1,155,000 2,180,000 40,217,000
Net Cash Flow From Investing Activities -1,850,000 -900,000 -2,016,000 -260,782,000
Net Cash Flow From Investing Activities, Continuing -1,850,000 -900,000 -2,016,000 -260,782,000
Net Cash Flow From Operating Activities -17,770,000 -22,495,000 -12,454,000 -61,257,000
Net Cash Flow From Operating Activities, Continuing -17,770,000 -22,495,000 -12,454,000 -61,257,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-01 2018-08-01 2018-10-31 2019-02-27
Comprehensive Income/Loss -21,356,000 -22,219,000 -22,702,000 -85,371,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -21,356,000 -22,219,000 -22,702,000 -85,371,000
Other Comprehensive Income/Loss 0 0 0 -28,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB -28,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-01 2018-08-01 2018-10-31 2019-02-27
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 29,899,000 31,272,000 31,507,000 115,777,000
Cost Of Revenue 0 0 0 0
Costs And Expenses 29,899,000 31,272,000 31,507,000 121,304,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -21,356,000 -22,219,000 -22,702,000 -85,343,000
Income/Loss From Continuing Operations Before Tax -22,430,000 -23,595,000 -24,099,000 -85,343,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -21,356,000 -22,219,000 -22,702,000 -85,343,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -21,356,000 -22,219,000 -22,702,000 -85,343,000
Net Income/Loss Available To Common Stockholders, Basic -21,356,000 -22,219,000 -22,702,000 -85,343,000
Operating Expenses 29,899,000 31,272,000 31,507,000 121,304,000
Operating Income/Loss -22,430,000 -23,595,000 -24,099,000 -90,870,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 7,469,000 7,677,000 7,408,000 30,434,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-02 2017-08-01 2017-10-31 2018-03-14
Assets 279,263,000 264,975,000 249,170,000 376,235,000
Current Assets 261,078,000 245,919,000 229,053,000 354,830,000
Current Liabilities 24,910,000 26,371,000 25,786,000 31,359,000
Equity 199,883,000 187,585,000 175,847,000 300,597,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 199,883,000 187,585,000 175,847,000 300,597,000
Liabilities 79,380,000 77,390,000 73,323,000 75,638,000
Liabilities And Equity 279,263,000 264,975,000 249,170,000 376,235,000
Noncurrent Assets 18,185,000 19,056,000 20,117,000 21,405,000
Noncurrent Liabilities 54,470,000 51,019,000 47,537,000 44,279,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-02 2017-08-01 2017-10-31 2018-03-14
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -15,513,000 -16,504,000 -18,783,000 67,614,000
Net Cash Flow, Continuing -15,513,000 -16,504,000 -18,783,000 67,614,000
Net Cash Flow From Financing Activities 47,000 446,000 371,000 142,981,000
Net Cash Flow From Financing Activities, Continuing 47,000 446,000 371,000 142,981,000
Net Cash Flow From Investing Activities -4,162,000 -1,272,000 -2,260,000 -10,091,000
Net Cash Flow From Investing Activities, Continuing -4,162,000 -1,272,000 -2,260,000 -10,091,000
Net Cash Flow From Operating Activities -11,398,000 -15,678,000 -16,894,000 -65,276,000
Net Cash Flow From Operating Activities, Continuing -11,398,000 -15,678,000 -16,894,000 -65,276,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-02 2017-08-01 2017-10-31 2018-03-14
Comprehensive Income/Loss -12,631,000 -15,593,000 -15,356,000 -67,543,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -12,631,000 -15,593,000 -15,356,000 -67,543,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-02 2017-08-01 2017-10-31 2018-03-14
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 19,163,000 21,934,000 23,192,000 93,660,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 19,163,000 21,934,000 23,192,000 95,672,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -12,631,000 -15,593,000 -15,356,000 -67,543,000
Income/Loss From Continuing Operations Before Tax -12,948,000 -16,017,000 -15,875,000 -67,543,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -12,631,000 -15,593,000 -15,356,000 -67,543,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -12,631,000 -15,593,000 -15,356,000 -67,543,000
Net Income/Loss Available To Common Stockholders, Basic -12,631,000 -15,593,000 -15,356,000 -67,543,000
Operating Expenses 19,163,000 21,934,000 23,192,000 95,672,000
Operating Income/Loss -12,948,000 -16,017,000 -15,875,000 -69,555,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 6,215,000 5,917,000 7,317,000 26,117,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2016-08-04 2016-11-01 2017-03-14
Assets UNPUB 310,624,000 301,469,000 298,969,000
Current Assets UNPUB 302,904,000 292,702,000 281,306,000
Current Liabilities UNPUB 21,617,000 22,633,000 30,730,000
Equity UNPUB 223,602,000 218,124,000 209,837,000
Equity Attributable To Noncontrolling Interest UNPUB 0 0 0
Equity Attributable To Parent UNPUB 223,602,000 218,124,000 209,837,000
Liabilities UNPUB 87,022,000 83,345,000 89,132,000
Liabilities And Equity UNPUB 310,624,000 301,469,000 298,969,000
Noncurrent Assets UNPUB 7,720,000 8,767,000 17,663,000
Noncurrent Liabilities UNPUB 65,405,000 60,712,000 58,402,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2016-08-04 2016-11-01 2017-03-14
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow UNPUB 236,495,000 -10,069,000 197,248,000
Net Cash Flow, Continuing UNPUB 236,495,000 -10,069,000 197,248,000
Net Cash Flow From Financing Activities UNPUB 170,092,000 -1,854,000 167,304,000
Net Cash Flow From Financing Activities, Continuing UNPUB 170,092,000 -1,854,000 167,304,000
Net Cash Flow From Investing Activities UNPUB -1,147,000 -605,000 -6,165,000
Net Cash Flow From Investing Activities, Continuing UNPUB -1,147,000 -605,000 -6,165,000
Net Cash Flow From Operating Activities UNPUB 67,550,000 -7,610,000 36,109,000
Net Cash Flow From Operating Activities, Continuing UNPUB 67,550,000 -7,610,000 36,109,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2016-08-04 2016-11-01 2017-03-14
Comprehensive Income/Loss UNPUB -6,900,000 -7,482,000 -31,634,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest UNPUB 0 0 0
Comprehensive Income/Loss Attributable To Parent UNPUB -6,900,000 -7,482,000 -31,634,000
Other Comprehensive Income/Loss UNPUB 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2016-08-04 2016-11-01 2017-03-14
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB 11,106,000 12,351,000 48,113,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB 11,152,000 12,566,000 48,638,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax UNPUB -6,900,000 -7,482,000 -31,634,000
Income/Loss From Continuing Operations Before Tax UNPUB -6,900,000 -7,482,000 -31,634,000
Income Tax Expense/Benefit UNPUB 0 0 0
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss UNPUB -6,900,000 -7,482,000 -31,634,000
Net Income/Loss Attributable To Noncontrolling Interest UNPUB 0 0 0
Net Income/Loss Attributable To Parent UNPUB -6,900,000 -7,482,000 -31,634,000
Net Income/Loss Available To Common Stockholders, Basic UNPUB -6,900,000 -7,482,000 -31,634,000
Operating Expenses UNPUB 11,152,000 12,566,000 48,638,000
Operating Income/Loss UNPUB -6,946,000 -7,697,000 -32,159,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic UNPUB 0 0 0
Preferred Stock Dividends And Other Adjustments UNPUB 0 0 0
Revenues UNPUB 4,206,000 4,869,000 16,479,000
Calendar
20 May 2024 (Time UTC) Actual Previous Consensus
★★
09:00
United States
★★
09:00
United States
19 May 2024 (Time UTC) Actual Previous Consensus
★★★
15:30
United States
17 May 2024 (Time UTC) Actual Previous Consensus
★
15:30
United States
-5400.000
-17800.000
★
15:30
United States
-66000.000
-60000.000
★
15:30
United States
59500.000
53700.000
★
15:30
United States
-116600.000
-135800.000
★★
15:30
United States
3200.000
4400.000
★
15:30
United States
203000.000
215400.000
★
15:30
United States
200.000
-31400.000
★
15:30
United States
61800.000
62600.000
★
15:30
United States
1300.000
1300.000
★
15:30
United States
-25300.000
-9700.000
★
15:30
United States
204500.000
199600.000
★★
15:30
United States
Options
Ticker
CFI
Contract Type
Exercise Style
Share Per Contract
Strike Price
Primary Exchange
Expiration Date
O:NTLA240517C00012500 OCASPS Call American 100 12.5 BATO 2024-05-17
O:NTLA240517P00040000 OPASPS Put American 100 40 BATO 2024-05-17
O:NTLA240517P00035000 OPASPS Put American 100 35 BATO 2024-05-17
O:NTLA240517P00030000 OPASPS Put American 100 30 BATO 2024-05-17
O:NTLA240517P00025000 OPASPS Put American 100 25 BATO 2024-05-17
O:NTLA240517P00022500 OPASPS Put American 100 22.5 BATO 2024-05-17
O:NTLA240517P00020000 OPASPS Put American 100 20 BATO 2024-05-17
O:NTLA240517P00017500 OPASPS Put American 100 17.5 BATO 2024-05-17
O:NTLA240517P00015000 OPASPS Put American 100 15 BATO 2024-05-17
O:NTLA240517C00040000 OCASPS Call American 100 40 BATO 2024-05-17
O:NTLA240517C00035000 OCASPS Call American 100 35 BATO 2024-05-17
O:NTLA240517C00030000 OCASPS Call American 100 30 BATO 2024-05-17
O:NTLA240517C00025000 OCASPS Call American 100 25 BATO 2024-05-17
O:NTLA240517C00022500 OCASPS Call American 100 22.5 BATO 2024-05-17
O:NTLA240517C00020000 OCASPS Call American 100 20 BATO 2024-05-17
O:NTLA240517C00017500 OCASPS Call American 100 17.5 BATO 2024-05-17
O:NTLA240517C00015000 OCASPS Call American 100 15 BATO 2024-05-17
O:NTLA240517P00012500 OPASPS Put American 100 12.5 BATO 2024-05-17
O:NTLA240419P00055000 OPASPS Put American 100 55 BATO 2024-04-19
O:NTLA240419P00050000 OPASPS Put American 100 50 BATO 2024-04-19
O:NTLA240419P00045000 OPASPS Put American 100 45 BATO 2024-04-19
O:NTLA240419P00040000 OPASPS Put American 100 40 BATO 2024-04-19
O:NTLA240419P00035000 OPASPS Put American 100 35 BATO 2024-04-19
O:NTLA240419P00030000 OPASPS Put American 100 30 BATO 2024-04-19
O:NTLA240419P00025000 OPASPS Put American 100 25 BATO 2024-04-19
O:NTLA240419P00022500 OPASPS Put American 100 22.5 BATO 2024-04-19
O:NTLA240419P00020000 OPASPS Put American 100 20 BATO 2024-04-19
O:NTLA240419C00055000 OCASPS Call American 100 55 BATO 2024-04-19
O:NTLA240419C00050000 OCASPS Call American 100 50 BATO 2024-04-19
O:NTLA240419C00045000 OCASPS Call American 100 45 BATO 2024-04-19
O:NTLA240419C00040000 OCASPS Call American 100 40 BATO 2024-04-19
O:NTLA240419C00035000 OCASPS Call American 100 35 BATO 2024-04-19
O:NTLA240419C00030000 OCASPS Call American 100 30 BATO 2024-04-19
O:NTLA240419C00025000 OCASPS Call American 100 25 BATO 2024-04-19
O:NTLA240419C00022500 OCASPS Call American 100 22.5 BATO 2024-04-19
O:NTLA240419C00020000 OCASPS Call American 100 20 BATO 2024-04-19
O:NTLA240419P00012500 OPASPS Put American 100 12.5 BATO 2024-04-19
O:NTLA240419C00012500 OCASPS Call American 100 12.5 BATO 2024-04-19
O:NTLA240419P00017500 OPASPS Put American 100 17.5 BATO 2024-04-19
O:NTLA240419P00015000 OPASPS Put American 100 15 BATO 2024-04-19
O:NTLA240419C00015000 OCASPS Call American 100 15 BATO 2024-04-19
O:NTLA240419C00017500 OCASPS Call American 100 17.5 BATO 2024-04-19
O:NTLA240315P00040000 OPASPS Put American 100 40 BATO 2024-03-15
O:NTLA240315P00035000 OPASPS Put American 100 35 BATO 2024-03-15
O:NTLA240315P00030000 OPASPS Put American 100 30 BATO 2024-03-15
O:NTLA240315P00025000 OPASPS Put American 100 25 BATO 2024-03-15
O:NTLA240315P00022500 OPASPS Put American 100 22.5 BATO 2024-03-15
O:NTLA240315P00020000 OPASPS Put American 100 20 BATO 2024-03-15
O:NTLA240315P00017500 OPASPS Put American 100 17.5 BATO 2024-03-15
O:NTLA240315P00015000 OPASPS Put American 100 15 BATO 2024-03-15
O:NTLA240315C00040000 OCASPS Call American 100 40 BATO 2024-03-15
O:NTLA240315C00035000 OCASPS Call American 100 35 BATO 2024-03-15
O:NTLA240315C00030000 OCASPS Call American 100 30 BATO 2024-03-15
O:NTLA240315C00025000 OCASPS Call American 100 25 BATO 2024-03-15
O:NTLA240315C00022500 OCASPS Call American 100 22.5 BATO 2024-03-15
O:NTLA240315C00020000 OCASPS Call American 100 20 BATO 2024-03-15
O:NTLA240315C00017500 OCASPS Call American 100 17.5 BATO 2024-03-15
O:NTLA240315C00015000 OCASPS Call American 100 15 BATO 2024-03-15
O:NTLA240315P00012500 OPASPS Put American 100 12.5 BATO 2024-03-15
O:NTLA240315C00012500 OCASPS Call American 100 12.5 BATO 2024-03-15
O:NTLA240216P00045000 OPASPS Put American 100 45 BATO 2024-02-16
O:NTLA240216P00040000 OPASPS Put American 100 40 BATO 2024-02-16
O:NTLA240216P00035000 OPASPS Put American 100 35 BATO 2024-02-16
O:NTLA240216P00030000 OPASPS Put American 100 30 BATO 2024-02-16
O:NTLA240216P00025000 OPASPS Put American 100 25 BATO 2024-02-16
O:NTLA240216P00022500 OPASPS Put American 100 22.5 BATO 2024-02-16
O:NTLA240216P00020000 OPASPS Put American 100 20 BATO 2024-02-16
O:NTLA240216P00017500 OPASPS Put American 100 17.5 BATO 2024-02-16
O:NTLA240216P00015000 OPASPS Put American 100 15 BATO 2024-02-16
O:NTLA240216C00045000 OCASPS Call American 100 45 BATO 2024-02-16
O:NTLA240216C00040000 OCASPS Call American 100 40 BATO 2024-02-16
O:NTLA240216C00035000 OCASPS Call American 100 35 BATO 2024-02-16
O:NTLA240216C00030000 OCASPS Call American 100 30 BATO 2024-02-16
O:NTLA240216C00025000 OCASPS Call American 100 25 BATO 2024-02-16
O:NTLA240216C00022500 OCASPS Call American 100 22.5 BATO 2024-02-16
O:NTLA240216C00020000 OCASPS Call American 100 20 BATO 2024-02-16
O:NTLA240216C00017500 OCASPS Call American 100 17.5 BATO 2024-02-16
O:NTLA240216C00015000 OCASPS Call American 100 15 BATO 2024-02-16
O:NTLA240119P00012500 OPASPS Put American 100 12.5 BATO 2024-01-19
O:NTLA240119C00012500 OCASPS Call American 100 12.5 BATO 2024-01-19
O:NTLA240119P00015000 OPASPS Put American 100 15 BATO 2024-01-19
O:NTLA240119C00015000 OCASPS Call American 100 15 BATO 2024-01-19
O:NTLA240119P00230000 OPASPS Put American 100 230 BATO 2024-01-19
O:NTLA240119P00220000 OPASPS Put American 100 220 BATO 2024-01-19
O:NTLA240119P00210000 OPASPS Put American 100 210 BATO 2024-01-19
O:NTLA240119P00200000 OPASPS Put American 100 200 BATO 2024-01-19
O:NTLA240119P00195000 OPASPS Put American 100 195 BATO 2024-01-19
O:NTLA240119P00190000 OPASPS Put American 100 190 BATO 2024-01-19
O:NTLA240119P00185000 OPASPS Put American 100 185 BATO 2024-01-19
O:NTLA240119P00180000 OPASPS Put American 100 180 BATO 2024-01-19
O:NTLA240119P00175000 OPASPS Put American 100 175 BATO 2024-01-19
O:NTLA240119P00170000 OPASPS Put American 100 170 BATO 2024-01-19
O:NTLA240119P00165000 OPASPS Put American 100 165 BATO 2024-01-19
O:NTLA240119P00160000 OPASPS Put American 100 160 BATO 2024-01-19
O:NTLA240119P00155000 OPASPS Put American 100 155 BATO 2024-01-19
O:NTLA240119P00150000 OPASPS Put American 100 150 BATO 2024-01-19
O:NTLA240119P00145000 OPASPS Put American 100 145 BATO 2024-01-19
O:NTLA240119P00140000 OPASPS Put American 100 140 BATO 2024-01-19
O:NTLA240119P00135000 OPASPS Put American 100 135 BATO 2024-01-19
O:NTLA240119P00130000 OPASPS Put American 100 130 BATO 2024-01-19
O:NTLA240119P00125000 OPASPS Put American 100 125 BATO 2024-01-19
O:NTLA240119P00120000 OPASPS Put American 100 120 BATO 2024-01-19
O:NTLA240119P00115000 OPASPS Put American 100 115 BATO 2024-01-19
O:NTLA240119P00110000 OPASPS Put American 100 110 BATO 2024-01-19
O:NTLA240119P00105000 OPASPS Put American 100 105 BATO 2024-01-19
O:NTLA240119P00100000 OPASPS Put American 100 100 BATO 2024-01-19
O:NTLA240119P00095000 OPASPS Put American 100 95 BATO 2024-01-19
O:NTLA240119P00090000 OPASPS Put American 100 90 BATO 2024-01-19
O:NTLA240119P00085000 OPASPS Put American 100 85 BATO 2024-01-19
O:NTLA240119P00080000 OPASPS Put American 100 80 BATO 2024-01-19
O:NTLA240119P00075000 OPASPS Put American 100 75 BATO 2024-01-19
O:NTLA240119P00070000 OPASPS Put American 100 70 BATO 2024-01-19
O:NTLA240119P00065000 OPASPS Put American 100 65 BATO 2024-01-19
O:NTLA240119P00060000 OPASPS Put American 100 60 BATO 2024-01-19
O:NTLA240119P00055000 OPASPS Put American 100 55 BATO 2024-01-19
O:NTLA240119P00050000 OPASPS Put American 100 50 BATO 2024-01-19
O:NTLA240119P00045000 OPASPS Put American 100 45 BATO 2024-01-19
O:NTLA240119P00040000 OPASPS Put American 100 40 BATO 2024-01-19
O:NTLA240119P00035000 OPASPS Put American 100 35 BATO 2024-01-19
O:NTLA240119P00030000 OPASPS Put American 100 30 BATO 2024-01-19
O:NTLA240119P00025000 OPASPS Put American 100 25 BATO 2024-01-19
O:NTLA240119P00022500 OPASPS Put American 100 22.5 BATO 2024-01-19
O:NTLA240119P00020000 OPASPS Put American 100 20 BATO 2024-01-19
O:NTLA240119P00017500 OPASPS Put American 100 17.5 BATO 2024-01-19
O:NTLA240119C00230000 OCASPS Call American 100 230 BATO 2024-01-19
O:NTLA240119C00220000 OCASPS Call American 100 220 BATO 2024-01-19
O:NTLA240119C00210000 OCASPS Call American 100 210 BATO 2024-01-19
O:NTLA240119C00200000 OCASPS Call American 100 200 BATO 2024-01-19
O:NTLA240119C00195000 OCASPS Call American 100 195 BATO 2024-01-19
O:NTLA240119C00190000 OCASPS Call American 100 190 BATO 2024-01-19
O:NTLA240119C00185000 OCASPS Call American 100 185 BATO 2024-01-19
O:NTLA240119C00180000 OCASPS Call American 100 180 BATO 2024-01-19
O:NTLA240119C00175000 OCASPS Call American 100 175 BATO 2024-01-19
O:NTLA240119C00170000 OCASPS Call American 100 170 BATO 2024-01-19
O:NTLA240119C00165000 OCASPS Call American 100 165 BATO 2024-01-19
O:NTLA240119C00160000 OCASPS Call American 100 160 BATO 2024-01-19
O:NTLA240119C00155000 OCASPS Call American 100 155 BATO 2024-01-19
O:NTLA240119C00150000 OCASPS Call American 100 150 BATO 2024-01-19
O:NTLA240119C00145000 OCASPS Call American 100 145 BATO 2024-01-19
O:NTLA240119C00140000 OCASPS Call American 100 140 BATO 2024-01-19
O:NTLA240119C00135000 OCASPS Call American 100 135 BATO 2024-01-19
O:NTLA240119C00130000 OCASPS Call American 100 130 BATO 2024-01-19
O:NTLA240119C00125000 OCASPS Call American 100 125 BATO 2024-01-19
O:NTLA240119C00120000 OCASPS Call American 100 120 BATO 2024-01-19
O:NTLA240119C00115000 OCASPS Call American 100 115 BATO 2024-01-19
O:NTLA240119C00110000 OCASPS Call American 100 110 BATO 2024-01-19
O:NTLA240119C00105000 OCASPS Call American 100 105 BATO 2024-01-19
O:NTLA240119C00100000 OCASPS Call American 100 100 BATO 2024-01-19
O:NTLA240119C00095000 OCASPS Call American 100 95 BATO 2024-01-19
O:NTLA240119C00090000 OCASPS Call American 100 90 BATO 2024-01-19
O:NTLA240119C00085000 OCASPS Call American 100 85 BATO 2024-01-19
O:NTLA240119C00080000 OCASPS Call American 100 80 BATO 2024-01-19
O:NTLA240119C00075000 OCASPS Call American 100 75 BATO 2024-01-19
O:NTLA240119C00070000 OCASPS Call American 100 70 BATO 2024-01-19
O:NTLA240119C00065000 OCASPS Call American 100 65 BATO 2024-01-19
O:NTLA240119C00060000 OCASPS Call American 100 60 BATO 2024-01-19
O:NTLA240119C00055000 OCASPS Call American 100 55 BATO 2024-01-19
O:NTLA240119C00050000 OCASPS Call American 100 50 BATO 2024-01-19
O:NTLA240119C00045000 OCASPS Call American 100 45 BATO 2024-01-19
O:NTLA240119C00040000 OCASPS Call American 100 40 BATO 2024-01-19
O:NTLA240119C00035000 OCASPS Call American 100 35 BATO 2024-01-19
O:NTLA240119C00030000 OCASPS Call American 100 30 BATO 2024-01-19
O:NTLA240119C00025000 OCASPS Call American 100 25 BATO 2024-01-19
O:NTLA240119C00022500 OCASPS Call American 100 22.5 BATO 2024-01-19
O:NTLA240119C00020000 OCASPS Call American 100 20 BATO 2024-01-19
O:NTLA240119C00017500 OCASPS Call American 100 17.5 BATO 2024-01-19
O:NTLA231215P00012500 OPASPS Put American 100 12.5 BATO 2023-12-15
O:NTLA231215C00012500 OCASPS Call American 100 12.5 BATO 2023-12-15
O:NTLA231215P00040000 OPASPS Put American 100 40 BATO 2023-12-15
O:NTLA231215P00035000 OPASPS Put American 100 35 BATO 2023-12-15
O:NTLA231215P00030000 OPASPS Put American 100 30 BATO 2023-12-15
O:NTLA231215P00025000 OPASPS Put American 100 25 BATO 2023-12-15
O:NTLA231215P00022500 OPASPS Put American 100 22.5 BATO 2023-12-15
O:NTLA231215P00020000 OPASPS Put American 100 20 BATO 2023-12-15
O:NTLA231215P00017500 OPASPS Put American 100 17.5 BATO 2023-12-15
O:NTLA231215P00015000 OPASPS Put American 100 15 BATO 2023-12-15
O:NTLA231215C00040000 OCASPS Call American 100 40 BATO 2023-12-15
O:NTLA231215C00035000 OCASPS Call American 100 35 BATO 2023-12-15
O:NTLA231215C00030000 OCASPS Call American 100 30 BATO 2023-12-15
O:NTLA231215C00025000 OCASPS Call American 100 25 BATO 2023-12-15
O:NTLA231215C00022500 OCASPS Call American 100 22.5 BATO 2023-12-15
O:NTLA231215C00020000 OCASPS Call American 100 20 BATO 2023-12-15
O:NTLA231215C00017500 OCASPS Call American 100 17.5 BATO 2023-12-15
O:NTLA231215C00015000 OCASPS Call American 100 15 BATO 2023-12-15
O:NTLA231117P00030000 OPASPS Put American 100 30 BATO 2023-11-17
O:NTLA231117P00025000 OPASPS Put American 100 25 BATO 2023-11-17
O:NTLA231117P00022500 OPASPS Put American 100 22.5 BATO 2023-11-17
O:NTLA231117P00020000 OPASPS Put American 100 20 BATO 2023-11-17
O:NTLA231117P00017500 OPASPS Put American 100 17.5 BATO 2023-11-17
O:NTLA231117C00055000 OCASPS Call American 100 55 BATO 2023-11-17
O:NTLA231117C00050000 OCASPS Call American 100 50 BATO 2023-11-17
O:NTLA231117C00045000 OCASPS Call American 100 45 BATO 2023-11-17
O:NTLA231117C00040000 OCASPS Call American 100 40 BATO 2023-11-17
O:NTLA231117C00035000 OCASPS Call American 100 35 BATO 2023-11-17
O:NTLA231117C00030000 OCASPS Call American 100 30 BATO 2023-11-17
O:NTLA231117C00025000 OCASPS Call American 100 25 BATO 2023-11-17
O:NTLA231117C00022500 OCASPS Call American 100 22.5 BATO 2023-11-17
O:NTLA231117C00020000 OCASPS Call American 100 20 BATO 2023-11-17
O:NTLA231117C00017500 OCASPS Call American 100 17.5 BATO 2023-11-17
O:NTLA231117P00015000 OPASPS Put American 100 15 BATO 2023-11-17
O:NTLA231117C00015000 OCASPS Call American 100 15 BATO 2023-11-17
O:NTLA231117P00012500 OPASPS Put American 100 12.5 BATO 2023-11-17
O:NTLA231117C00012500 OCASPS Call American 100 12.5 BATO 2023-11-17
O:NTLA231117P00055000 OPASPS Put American 100 55 BATO 2023-11-17
O:NTLA231117P00050000 OPASPS Put American 100 50 BATO 2023-11-17
O:NTLA231117P00045000 OPASPS Put American 100 45 BATO 2023-11-17
O:NTLA231117P00040000 OPASPS Put American 100 40 BATO 2023-11-17
O:NTLA231117P00035000 OPASPS Put American 100 35 BATO 2023-11-17
O:NTLA231020P00015000 OPASPS Put American 100 15 BATO 2023-10-20
O:NTLA231020C00015000 OCASPS Call American 100 15 BATO 2023-10-20
O:NTLA231020P00065000 OPASPS Put American 100 65 BATO 2023-10-20
O:NTLA231020P00060000 OPASPS Put American 100 60 BATO 2023-10-20
O:NTLA231020P00055000 OPASPS Put American 100 55 BATO 2023-10-20
O:NTLA231020P00050000 OPASPS Put American 100 50 BATO 2023-10-20
O:NTLA231020P00045000 OPASPS Put American 100 45 BATO 2023-10-20
O:NTLA231020P00040000 OPASPS Put American 100 40 BATO 2023-10-20
O:NTLA231020P00035000 OPASPS Put American 100 35 BATO 2023-10-20
O:NTLA231020P00030000 OPASPS Put American 100 30 BATO 2023-10-20
O:NTLA231020P00025000 OPASPS Put American 100 25 BATO 2023-10-20
O:NTLA231020P00022500 OPASPS Put American 100 22.5 BATO 2023-10-20
O:NTLA231020P00020000 OPASPS Put American 100 20 BATO 2023-10-20
O:NTLA231020P00017500 OPASPS Put American 100 17.5 BATO 2023-10-20
O:NTLA231020C00065000 OCASPS Call American 100 65 BATO 2023-10-20
O:NTLA231020C00060000 OCASPS Call American 100 60 BATO 2023-10-20
O:NTLA231020C00055000 OCASPS Call American 100 55 BATO 2023-10-20
O:NTLA231020C00050000 OCASPS Call American 100 50 BATO 2023-10-20
O:NTLA231020C00045000 OCASPS Call American 100 45 BATO 2023-10-20
O:NTLA231020C00040000 OCASPS Call American 100 40 BATO 2023-10-20
O:NTLA231020C00035000 OCASPS Call American 100 35 BATO 2023-10-20
O:NTLA231020C00030000 OCASPS Call American 100 30 BATO 2023-10-20
O:NTLA231020C00025000 OCASPS Call American 100 25 BATO 2023-10-20
O:NTLA231020C00022500 OCASPS Call American 100 22.5 BATO 2023-10-20
O:NTLA231020C00020000 OCASPS Call American 100 20 BATO 2023-10-20
O:NTLA231020C00017500 OCASPS Call American 100 17.5 BATO 2023-10-20
O:NTLA230915P00020000 OPASPS Put American 100 20 BATO 2023-09-15
O:NTLA230915C00020000 OCASPS Call American 100 20 BATO 2023-09-15
O:NTLA230915P00065000 OPASPS Put American 100 65 BATO 2023-09-15
O:NTLA230915P00060000 OPASPS Put American 100 60 BATO 2023-09-15
O:NTLA230915P00055000 OPASPS Put American 100 55 BATO 2023-09-15
O:NTLA230915P00050000 OPASPS Put American 100 50 BATO 2023-09-15
O:NTLA230915P00045000 OPASPS Put American 100 45 BATO 2023-09-15
O:NTLA230915P00040000 OPASPS Put American 100 40 BATO 2023-09-15
O:NTLA230915P00035000 OPASPS Put American 100 35 BATO 2023-09-15
O:NTLA230915P00030000 OPASPS Put American 100 30 BATO 2023-09-15
O:NTLA230915P00025000 OPASPS Put American 100 25 BATO 2023-09-15
O:NTLA230915P00022500 OPASPS Put American 100 22.5 BATO 2023-09-15
O:NTLA230915C00065000 OCASPS Call American 100 65 BATO 2023-09-15
O:NTLA230915C00060000 OCASPS Call American 100 60 BATO 2023-09-15
O:NTLA230915C00055000 OCASPS Call American 100 55 BATO 2023-09-15
O:NTLA230915C00050000 OCASPS Call American 100 50 BATO 2023-09-15
O:NTLA230915C00045000 OCASPS Call American 100 45 BATO 2023-09-15
O:NTLA230915C00040000 OCASPS Call American 100 40 BATO 2023-09-15
O:NTLA230915C00035000 OCASPS Call American 100 35 BATO 2023-09-15
O:NTLA230915C00030000 OCASPS Call American 100 30 BATO 2023-09-15
O:NTLA230915C00025000 OCASPS Call American 100 25 BATO 2023-09-15
O:NTLA230915C00022500 OCASPS Call American 100 22.5 BATO 2023-09-15
O:NTLA230818P00020000 OPASPS Put American 100 20 BATO 2023-08-18
O:NTLA230818C00020000 OCASPS Call American 100 20 BATO 2023-08-18
O:NTLA230818P00065000 OPASPS Put American 100 65 BATO 2023-08-18
O:NTLA230818P00060000 OPASPS Put American 100 60 BATO 2023-08-18
O:NTLA230818P00055000 OPASPS Put American 100 55 BATO 2023-08-18
O:NTLA230818P00050000 OPASPS Put American 100 50 BATO 2023-08-18
O:NTLA230818P00045000 OPASPS Put American 100 45 BATO 2023-08-18
O:NTLA230818P00040000 OPASPS Put American 100 40 BATO 2023-08-18
O:NTLA230818P00035000 OPASPS Put American 100 35 BATO 2023-08-18
O:NTLA230818P00030000 OPASPS Put American 100 30 BATO 2023-08-18
O:NTLA230818P00025000 OPASPS Put American 100 25 BATO 2023-08-18
O:NTLA230818P00022500 OPASPS Put American 100 22.5 BATO 2023-08-18
O:NTLA230818C00065000 OCASPS Call American 100 65 BATO 2023-08-18
O:NTLA230818C00060000 OCASPS Call American 100 60 BATO 2023-08-18
O:NTLA230818C00055000 OCASPS Call American 100 55 BATO 2023-08-18
O:NTLA230818C00050000 OCASPS Call American 100 50 BATO 2023-08-18
O:NTLA230818C00045000 OCASPS Call American 100 45 BATO 2023-08-18
O:NTLA230818C00040000 OCASPS Call American 100 40 BATO 2023-08-18
O:NTLA230818C00035000 OCASPS Call American 100 35 BATO 2023-08-18
O:NTLA230818C00030000 OCASPS Call American 100 30 BATO 2023-08-18
O:NTLA230818C00025000 OCASPS Call American 100 25 BATO 2023-08-18
O:NTLA230818C00022500 OCASPS Call American 100 22.5 BATO 2023-08-18
News Stream
Stocks Earnings Releases and Operating Results
Intellia Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
CAMBRIDGE, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today reported operational highlights and financial results for the first quarter ended March 31, 2024.
GlobeNewswire Inc. • 1w ago
Calendar Calendar of Events
Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2024 Earnings and Company Updates
CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, will present its first quarter 2024 financial results and operational highlights in a conference call on May 9, 2024, at 8 a.m. ET.
GlobeNewswire Inc. • 2w ago
News Clinical Study
Intellia Therapeutics to Present Updated Data from Phase 1/2 Study of NTLA-2002 for the Treatment of Hereditary Angioedema (HAE) at the EAACI Congress 2024
CAMBRIDGE, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced the acceptance of an oral presentation from the Phase 1 portion of the ongoing NTLA-2002 Phase 1/2 study at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2024, taking place May 31 – June 3 in Valencia, Spain. NTLA-2002 is an investigational in vivo CRISPR-based gene editing therapy in development as a single-dose treatment for hereditary angioedema (HAE), a rare genetic condition that leads to potentially life-threatening swelling attacks. The presentation will include updated safety and efficacy results from the Phase 1 study across all three dose cohorts (25 mg, 50 mg and 75 mg).
GlobeNewswire Inc. • 2w ago
News Clinical Study
Intellia Therapeutics Announces First Patient Dosed in the Phase 3 MAGNITUDE Study of NTLA-2001 as a Single-Dose CRISPR-Based Treatment for Transthyretin Amyloidosis with Cardiomyopathy
CAMBRIDGE, Mass., March 18, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced the first patient dosed in the global pivotal, Phase 3 MAGNITUDE trial of NTLA-2001. NTLA-2001 is an investigational in vivo CRISPR-based therapy designed as a single-dose treatment to inactivate the TTR gene and thereby prevent the production of TTR protein for the treatment of transthyretin (ATTR) amyloidosis. The MAGNITUDE trial is evaluating the efficacy and safety of NTLA-2001 in patients with ATTR amyloidosis with cardiomyopathy.
GlobeNewswire Inc. • 2mo ago
Investing investing
Is Intellia Therapeutics Stock a Buy Now?
The company's future will depend on its innovative qualities.
The Motley Fool • 2mo ago
Investing investing
Intellia Therapeutics Stock Has 119% Upside, According to 1 Wall Street Analyst
2024 could see the start of its first late-stage clinical trials.
The Motley Fool • 2mo ago
News News
Intellia Therapeutics, Inc. (NTLA) Crossed Above the 50-Day Moving Average: What That Means for Investors
Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?
Zacks Investment Research • 2mo ago
Investing investing
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The popular money manager added to these three existing positions on Monday following disappointing financial updates earlier this month.
The Motley Fool • 2mo ago
News News
Intellia Therapeutics, Inc. (NTLA) Just Overtook the 20-Day Moving Average
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?
Zacks Investment Research • 2mo ago
News News
Wall Street Analysts See an 185.54% Upside in Intellia Therapeutics, Inc. (NTLA): Can the Stock Really Move This High?
The consensus price target hints at an 185.5% upside potential for Intellia Therapeutics, Inc. (NTLA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks Investment Research • 2mo ago
See All
Related
Latest

Contactez-nous dès aujourd'hui pour découvrir comment notre solution peut vous aider à tirer parti de la puissance des données.

CONTACTER UN EXPERT